Previously treated cases tested for RR-/MDR-TB (%) in Brazil
Brazil: Previously treated cases tested for RR-/MDR-TB was 72.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Brazil, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Brazil stood at 72.0%. That is the highest value across all 16 years on record.
Compared with earlier readings it is up 4,135.3% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Brazil peaked at 72.0% in 2023 and was at its lowest, 1.7%, in 2012.
Brazil ranks 128th of 180 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Brazil, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 61.0% | — |
| 2007 | 6.5% | -89.3% |
| 2010 | 5.8% | -10.8% |
| 2011 | 5.2% | -10.3% |
| 2012 | 1.7% | -67.3% |
| 2013 | 1.7% | +0.0% |
| 2015 | 35.0% | +1958.8% |
| 2016 | 35.0% | +0.0% |
| 2017 | 40.0% | +14.3% |
| 2018 | 56.0% | +40.0% |
| 2019 | 62.0% | +10.7% |
| 2020 | 66.0% | +6.5% |
| 2021 | 68.0% | +3.0% |
| 2022 | 69.0% | +1.5% |
| 2023 | 72.0% | +4.3% |
| 2024 | 72.0% | +0.0% |
Brazil compared with similar countries
- Brazil's 72.0% is below the median for upper middle income countries, which is 92.0%, 78% of the median. (52 countries reporting)
- Brazil's 72.0% is below the median for Latin America & Caribbean, which is 85.0%, 85% of the median. (29 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Brazil changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2015 | +1958.8% | 1.7% | 35.0% |
| 2007 | -89.3% | 61.0% | 6.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 33.8% | 6.5% | 61.0% | 2 |
| 2010s | 26.9% | 1.7% | 62.0% | 9 |
| 2020s | 69.4% | 66.0% | 72.0% | 5 |
Countries ranked near Brazil
More health data for Brazil
- Un projection of annual infant deaths, annual growth rate -1.86 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1539 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,496 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,476 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.66 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0296 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.63 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Brazil?
- Previously treated cases tested for rr-/mdr-tb in Brazil was 72.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Brazil?
- The highest recorded value was 72.0% in 2023.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Brazil?
- The lowest recorded value was 1.7% in 2012.
- How does Brazil rank for previously treated cases tested for rr-/mdr-tb?
- Brazil ranks 128th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Brazil?
- Over the last ten years it is up 4,135.3%. The long-run trend across the full record is volatile.
- Where does this Brazil data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).